SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership [amend]
SEC Accession No. 0001193125-11-353039
Filing Date
2011-12-27
Accepted
2011-12-27 17:23:58
Documents
1
Filing Date Changed
2011-12-27
Group Members
INVUS ADVISORS, L.L.C.INVUS C.V.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.INVUS, L.P.RAYMOND DEBBANEULYS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A d273616dsc13da.htm SC 13D/A 134972
  Complete submission text file 0001193125-11-353039.txt   136824
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC./DE (Subject) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60409 | Film No.: 111282698
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O THE INVUS GROUP, L.L.C. 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O THE INVUS GROUP, L.L.C. 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 212 371 1717
Invus, L.P. (Filed by) CIK: 0001404570 (see all company filings)

IRS No.: 830359143
Type: SC 13D/A